Search for: "Human Genome Sciences Inc. " Results 1 - 20 of 124
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Feb 2008, 8:03 pm
Singer -- On February 7, 2008, Human Genome Sciences, Inc. [read post]
4 Nov 2011, 9:58 am
San Diego - Human Genome Sciences, Inc., a biopharmaceutical company that uses human DNA sequences to develop protein and antibody drugs, recently received a ruling in its favor by the British Supreme Court in a patent dispute with Eli Lilly & Co. [read post]
4 Nov 2011, 4:34 am by tracey
Eli Lilly & Co v Human Genome Sciences Inc [2011] UKSC 51;  [2011] WLR (D)  312 “Since the Technical Board of Appeal of the European Patent Office had adopted a consistent approach to patents for biological material, the English courts should follow the principles of law set out in its decisions. [read post]
30 Jan 2011, 9:53 pm by Patent Docs
Human Genome Sciences Inc. v. [read post]
19 Jul 2011, 1:35 am by Dr. Stuart Baran
  In Human Genome Sciences Inc v Eli Lilly and Company [2010] EWCA Civ 33, all of these questions had to be considered before evaluating the validity of a patent owned by Human Genome Sciences (“HGS”). [read post]
11 Dec 2014, 2:16 pm by Ray Frager
The property, at 9911 Belward Campus Drive, is  289,900 square feet and 100 percent leased to Human Genome Sciences Inc. [read post]
30 Mar 2008, 8:24 pm
Human Genome Sciences Inc. v. [read post]
29 Oct 2012, 6:46 pm by Courtenay Brinckerhoff
In a complaint filed October 19, 2012, Biogen Idec MA Inc. joined patent holders such as Exelixis, Inc. and Human Genome Sciences, Inc., who are challenging the USPTO’s interpretation of 35 USC § 154(b)(1)(B)(i)). [read post]
1 Aug 2008, 7:24 am
Yesterday Mr Justice Kitchin delivered a mega-judgment in Eli Lilly & Co v Human Genome Sciences Inc, [2008] EWHC 1903 (Pat), yet another significant Patents Court for England and Wales decision on patent validity.In short, HGS owned a patent that disclosed the nucleotide and amino acid sequence of a novel member of the TNF ligand superfamily, the polypeptide Neutrokine-Ã [read post]
11 Nov 2011, 7:21 am
In its second intellectual property appeal (the first being Lucasfilm v Ainsworth [2011] UKSC 39 see my case note "Lucasfilm v Ansoworth The Supreme Court's First IP Appeal" 31 July 2011 IP/IT Update) the United Kingdom Supreme Court had to consider the way in which the requirement of industrial applicability extends to a patent for biological material. [read post]
24 Apr 2011, 8:43 pm by Patent Docs
Glaxo Group Ltd. et al. 2:11-cv-03065; filed April 12, 2011 in the Central District of California • Plaintiffs: Genentech, Inc.; City of Hope • Defendants: Glaxo Group Ltd.; GlaxoSmithKline LLC; Human Genome Sciences, Inc.; Lonza Biologics PLC; Lonza Biologics Inc. [read post]
6 Aug 2012, 3:44 am by sally
High Court (Queen’s Bench Division) Middleton v Allianz Iard SA [2012] EWHC 2287 (QB) (01 August 2012) Petrou v Bertoncello & Ors [2012] EWHC 2286 (QB) (01 August 2012) High Court (Patents Court) Lilly & Company v Human Genome Sciences Inc [2012] EWHC 2290 (Pat) (03 August 2012) Source: www.bailii.org [read post]
23 Apr 2011, 1:00 pm by Jay Eng
The hedge funds’ former manager allegedly traded on confidential information about negative results from a clinical trial for Human Genome Sciences Inc. [read post]
26 May 2009, 9:59 pm
Thomas Watkins, President and Chief Executive Officer of Human Genome Sciences, Inc. [read post]
3 Nov 2011, 3:42 am by sally
Supreme Court Rainy Sky SA & Orsd v Kookmin Bank [2011] UKSC 50 (2 November 2011) Human Genome Sciences Inc v Eli Lilly and Company [2011] UKSC 51 (2 November 2011) Court of Appeal (Civil Division) Smith & Anor v Jafton Properties Ltd [2011] EWCA Civ 1251 (02 November 2011) Shiva Ltd v Transport for London [2011] EWCA Civ 1189 (02 November 2011) High Court (Chancery Division) Business Dream Ltd, Re Insolvency Act 1986 [2011] EWHC 2860 (Ch) (02… [read post]